Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing

Jan de Beur, Suzanne M.Miller, Paul D.Weber, Thomas J.Peacock, MunroInsogna, KarlKumar, RajivRauch, FrankLuca, DianaCimms, TriciaScott Roberts, MarySan Martin, JavierCarpenter, Thomas O.2023-08-022023-08-022021Jan de Beur SM, Miller PD, Weber TJ, et al. Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing. J Bone Miner Res. 2021;36(12):2455-2456. doi:10.1002/jbmr.4317https://hdl.handle.net/1805/34682en-USAttribution 4.0 InternationalOsteomalaciaParaneoplastic syndromesHumanized monoclonal antibodiesReply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good ThingArticle